Compare MTX & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MTX | BHC |
|---|---|---|
| Founded | 1968 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.0B |
| IPO Year | 2004 | 1996 |
| Metric | MTX | BHC |
|---|---|---|
| Price | $77.91 | $5.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $82.00 | $8.00 |
| AVG Volume (30 Days) | 214.5K | ★ 1.7M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.68% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ 1.17 | N/A |
| Revenue | $2,072,600,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $5.66 | $4.61 |
| Revenue Next Year | $4.47 | N/A |
| P/E Ratio | $66.48 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $53.15 | $4.41 |
| 52 Week High | $84.34 | $8.69 |
| Indicator | MTX | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 55.44 | 42.76 |
| Support Level | $65.38 | $4.93 |
| Resistance Level | $84.34 | $5.62 |
| Average True Range (ATR) | 2.25 | 0.21 |
| MACD | -0.26 | -0.01 |
| Stochastic Oscillator | 40.19 | 16.35 |
Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.